User login
Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Nicholas Vogelzang at the Oncology Practice Summit in Las Vegas about how he treats patients with metastatic prostate cancer given the new agents that are now available and growing concerns about treatment costs and patient quality of life.
The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Nicholas Vogelzang at the Oncology Practice Summit in Las Vegas about how he treats patients with metastatic prostate cancer given the new agents that are now available and growing concerns about treatment costs and patient quality of life.
The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Nicholas Vogelzang at the Oncology Practice Summit in Las Vegas about how he treats patients with metastatic prostate cancer given the new agents that are now available and growing concerns about treatment costs and patient quality of life.
The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.